Champions Biotechnology, Inc. (CSBR.OB) Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts™
Champions Biotechnology, Inc., a leader in the development of advanced preclinical platforms and tumor-specific data to enhance and accelerate the value of oncology drugs, recently announced that the company has secured an agreement with Ortho Biotech Oncology Research & Development for the evaluation of a novel preclinical oncology therapeutic in Champions’ Biomerk Tumorgraft™ platform. Preliminary studies show that Tumorgrafts closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. The company utilizes its preclinical platform to evaluate potential drugs and to create a portfolio of novel therapeutic candidates. After completing early-stage development,…